Latest news with #EricVolkman
Yahoo
04-07-2025
- Business
- Yahoo
Why Summit Therapeutics Stock Soared 8% Higher Today
A large, well-capitalized peer is apparently interested in a partnership deal with the company. This could be worth up to $15 billion in total, according to a media report. 10 stocks we like better than Summit Therapeutics › One day before the July Fourth holiday, the stock of clinical-stage biotech Summit Therapeutics (NASDAQ: SMMT) exploded like a powerful fireworks display. Shares of the cancer-focused company leaped by 8%, on a media report that a well-known peer was interested in a licensing deal. That rise bettered the S&P 500's (SNPINDEX: ^GSPC) 0.8% increase by several orders of magnitude. The media outlet in question was Bloomberg, which that morning published an article asserting that AstraZeneca is in talks with Summit about a partnership between the two companies. According to unnamed "people familiar with the matter," the piece stated that such a partnership would center on the investigational lung cancer treatment ivonescimab. The drug, which Summit licenses from Chinese peer Akeso, has recently attracted much attention from the healthcare community and investors alike. This was due to its impressive performance in a late-stage clinical trial. Bloomberg's sources said that the terms of a potential deal were still being hashed out. They might include an up-front payment of several billion dollars, and several milestone payments over time (this kind of structure is common in pharmaceutical industry licensing/partnership arrangements). All told, a deal between the two companies could pay out as much as $15 billion. Both Summit and AstraZeneca declined comment on the Bloomberg article. When a drug development program attracts $15 billion worth of interest from a major industry player with deep pockets, it's almost indisputably a win. If the Bloomberg report is accurate and a deal is indeed in the works (and is ultimately agreed upon), it would open a great, powerful, and quick road to success for Summit. It's little wonder investors were so happy about the possibility. Before you buy stock in Summit Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Summit Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $692,914!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $963,866!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy. Why Summit Therapeutics Stock Soared 8% Higher Today was originally published by The Motley Fool
Yahoo
27-06-2025
- Automotive
- Yahoo
Why AI Stock Cerence Was Pushing Higher This Week
Its in-car, artificial intelligence-boosted technology will be prominent in an upcoming Mercedes model. The company also notched a win in a patent infringement dispute. 10 stocks we like better than Cerence › Two developments over the past few days have sent Cerence (NASDAQ: CRNC) stock skyward. According to data compiled by S&P Global Market Intelligence, shares of the company -- which specializes in developing artificial intelligence (AI) capabilities for in-car systems -- were rising by almost 13% week to date as of Friday before market open. Both developments occurred on Thursday, with the first being Cerence's announcement that its technology packed into Mercedes-Benz's latest in-car "infotainment" system will soon get its initial rollout. This tech, rolled into the storied carmaker's latest version of its Mercedes-Benz User Experience (MBUX), is to be included in the new, soon-to-be-released 2026 electric CLA sedan. The automotive incumbent and Cerence have been partnering on MBUX for quite some time. The version that's being introduced with the upcoming CLA features advanced conversational capabilities powered by Cerence's AI solutions. These include neural speech recognition and natural language understanding, among other features, the company said. Later that day, Cerence scored a victory with the U.S. Patent and Trademark Office (USPTO), which was considering a patent infringement claim made by Korean electronics giant Samsung. The USPTO granted Cerence's request for it not to move forward with a Samsung effort to challenge the validity of the disputed patents. While such a win doesn't necessarily mean Cerence will ultimately prevail in the case, it does tilt the proceeding in its favor. Of the two news items, I'd say the Mercedes one is the more significant. Drivers of the German company's cars are now going to have direct, and often meaningful, interactions with Cerence's technology. There's no better way to boost a company's reputation; hopefully for shareholders, the system will perform well on deployment. Before you buy stock in Cerence, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Cerence wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,731!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $945,846!* Now, it's worth noting Stock Advisor's total average return is 818% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends Cerence. The Motley Fool has a disclosure policy. Why AI Stock Cerence Was Pushing Higher This Week was originally published by The Motley Fool Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
26-06-2025
- Business
- Yahoo
Why Digital Realty Trust Stock Got Rocked Today
Analysts didn't like what they heard from a high-profile peer of the company and expressed their disappointment. As a result, investors weren't exactly hot on Digital Realty Trust's future either. 10 stocks we like better than Digital Realty Trust › It was a case of guilt by association with Digital Realty Trust's (NYSE: DLR) shares on Thursday. The company took it on the chin in sympathy with a peer that was hit by a series of bearish analyst takes. This sent Digital Realty's shares down, too, and the stock ended up closing the day 1.5% lower in value. By contrast, the benchmark S&P 500 index had a good trading session, rising by 0.8%. That peer is Equinix, and that negative pundit reaction came in the wake of the company's analyst day presentation. In that event, Equinix divulged that its adjusted funds from operations (AFFO) -- widely considered the most crucial profitability metric for REITs -- would take a hit in the near future. This is because there is currently heavy demand to quickly and substantially build out data center capacity. In turn, that's due to the considerable computing requirements of artificial intelligence (AI) functionalities. AI is in persistently high demand from a great many developers and users alike, as its successful implementation and usage could greatly help streamline a business's operations. Although Digital Realty is distinguishable from Equinix in a number of ways, it runs more or less the same type of business and leases similar facilities. So, the factors anticipated to negatively impact Equinix's fundamentals are sure to affect Digital Realty's numbers, too. That's understandable to a degree, but I don't think long-term Digital Realty shareholders -- a group that includes myself -- should be discouraged by this development. Data center demand is heavy and sure to stay that way, and it seems to me that the anticipated hits to AFFO will be largely short term in duration. Once the major build-outs occur, data sector real estate investment trusts (REITs) will be larger, more powerful, and better positioned for growth. Before you buy stock in Digital Realty Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Digital Realty Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,731!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $945,846!* Now, it's worth noting Stock Advisor's total average return is 818% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Eric Volkman has positions in Digital Realty Trust. The Motley Fool has positions in and recommends Digital Realty Trust and Equinix. The Motley Fool has a disclosure policy. Why Digital Realty Trust Stock Got Rocked Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-06-2025
- Business
- Yahoo
Why BlackSky Technology Stock Was Vaulting Skyward Last Week
The company announced what's effectively a pending upgrade of its satellite constellation. The Aros project has the potential to significantly enhance its capabilities. 10 stocks we like better than BlackSky Technology › Over the last few trading days, the shares of BlackSky Technology (NYSE: BKSY) were soaring toward the satellites the next-generation defense company uses to provide data to clients. The company's stock price rose 30% from market close June 13 to market close June 20, helped by news that it is expanding and strengthening its satellite network. On Tuesday morning, BlackSky took the wraps off its plans to expand its existing satellite constellation. It said it is doing so with a set of multispectral, large-area collection satellites that will beef up the capabilities of the company's network as a whole. The new satellites have collectively been named Aros. In its press release on the matter, the company wrote that it is currently working with development partners on the project, and hopes to launch the new hardware as soon as 2027. It added that it will give the company the ability to provide functionalities such as digital mapping and navigation at peerless scale and speed. BlackSky also said of Aros that it "will address upcoming gaps in the market as legacy large area collection satellites age out of service over the next few years and are replaced with lower collection capacity satellites." While BlackSky was eager to discuss the technological capabilities of Aros, it wasn't so willing to provide certain details of the project. It didn't identify any of its development partners, nor did it address its potential costs. Nevertheless, assuming the company can develop/implement it effectively, we can assume it'll make for quite the upgrade to the constellation currently in place. Before you buy stock in BlackSky Technology, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and BlackSky Technology wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why BlackSky Technology Stock Was Vaulting Skyward Last Week was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-06-2025
- Business
- Yahoo
Why AI Stock Astera Labs Was Crushing It This Week
The company has found an appropriate partner to help it win more AI-related business. It's teaming up with a specialty chipmaker based in Asia. 10 stocks we like better than Astera Labs › According to data compiled by S&P Global Market Intelligence, Astera Labs (NASDAQ: ALAB) stock's price was floating almost 11% higher week to date on early Friday morning. Investors were mainly reacting to news the tech infrastructure company reported about a new business tie-up with an Asian peer. On Monday, Astera and Taiwanese chipmaker AIChip Technologies announced in a joint press release that they have formed a strategic business partnership. Together, the two will aim to exploit opportunities afforded by sky-high demand for artificial intelligence (AI) functionalities. AIChip, which specializes in application-specific integrated circuit (ASIC) chips, and Astera are teaming up to offer "validated, interoperable solutions for hyperscalers building next-generation AI infrastructure," according to the press release. As the name suggests, a hyperscaler is essentially an extremely large data center. These are in vogue now due to the heavy resource requirements of AI. Astera and AIChip offered almost no details about their new partnership, including its financial parameters. Given that, it's tough to gauge how this collaboration might affect their fundamentals. Judging by the market's reaction, though, investors don't seem to mind -- teaming up on projects has clear potential to benefit both companies. I think AI companies like Astera are in the midst of a gold rush. I'd absolutely consider buying the stock. Before you buy stock in Astera Labs, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Astera Labs wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why AI Stock Astera Labs Was Crushing It This Week was originally published by The Motley Fool Sign in to access your portfolio
